Danhong injection attenuates isoproterenol-induced cardiac hypertrophy by regulating p38 and NF-κb pathway. 2016

Hao-Ping Mao, and Xing-Ye Wang, and Yun Hang Gao, and Yan-Xu Chang, and Lu Chen, and Zi-Chang Niu, and Ju-Qing Ai, and Xiu-Mei Gao
Tianjin State Key Laboratory of Modern Chinese Medicine, Key Laboratory of Pharmacology of Traditional Chinese Medicine Formulae, and Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China. Electronic address: haoping_mao@126.com.

BACKGROUND Danhong injection (DHI), derived from Rhizoma Salviae Miltiorrhizae (Salvia miltiorrhiza Bge., Labiatae, Danshen in Chinese) and Flos Carthami (Carthamus tinctorius L., Compositae, Salvia militiorrhiza Bunge), is an extensively-used Chinese material standardized clinical product for treatment of cardiovascular diseases. OBJECTIVE Cardiac hypertrophy (CH) is an adaptive response of cardiomyocytes. Long-lasting cardiac hypertrophy results in the loss of compensation by cardiomyocytes which could ultimately develop into heart failure. In the present study, we aimed to investigate the effect and exact mechanisms of DHI on isoproterenol (ISO)-induced CH. METHODS H9c2 cells and male Wistar rats were stimulated by ISO in the present study to establish CH models in vitro and in vivo. CCk-8 assay, Western blot, real time-polymerase chain reaction (RT-PCR), electrophoretic mobility shift assay (EMSA) and Echocardiography were used in the present study. RESULTS DHI significantly attenuated ISO-induced CH of H9c2 cells (p<0.01). DHI decreased ISO-induced atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) elevation both at the mRNA and protein levels (p<0.05 and p<0.01, respectively). Western blot showed that DHI down-regulated the phosphorylation of p38. Furthermore, we found that DHI inhibited the nuclear translocation and activation of NF-κb. Echocardiography from ISO-induced CH rats showed that DHI significantly decreased left ventricle (LV) mass, the thickness of the LV end-systolic posterior wall (LVPWs), and the LV end-diastolic posterior wall (LVPWd) elevated by ISO (p<0.01 and p<0.05, respectively). CONCLUSIONS These data demonstrate that DHI might exert anti-cardiac hypertrophic effects by regulating p38 and NF-κb pathway.

UI MeSH Term Description Entries
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D008297 Male Males
D008516 Medicine, Chinese Traditional A system of traditional medicine which is based on the beliefs and practices of the Chinese culture. Chinese Medicine, Traditional,Chung I Hsueh,Traditional Medicine, Chinese,Zhong Yi Xue,Chinese Traditional Medicine,Traditional Chinese Medicine,Traditional Tongue Assessment,Traditional Tongue Diagnosis,Hsueh, Chung I,Tongue Assessment, Traditional,Tongue Diagnoses, Traditional,Tongue Diagnosis, Traditional,Traditional Tongue Assessments,Traditional Tongue Diagnoses
D008517 Phytotherapy Use of plants or herbs to treat diseases or to alleviate pain. Herb Therapy,Herbal Therapy
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006332 Cardiomegaly Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES. Cardiac Hypertrophy,Enlarged Heart,Heart Hypertrophy,Heart Enlargement,Cardiac Hypertrophies,Enlargement, Heart,Heart Hypertrophies,Heart, Enlarged,Hypertrophies, Cardiac,Hypertrophies, Heart,Hypertrophy, Cardiac,Hypertrophy, Heart
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB

Related Publications

Hao-Ping Mao, and Xing-Ye Wang, and Yun Hang Gao, and Yan-Xu Chang, and Lu Chen, and Zi-Chang Niu, and Ju-Qing Ai, and Xiu-Mei Gao
June 2020, Cardiovascular toxicology,
Hao-Ping Mao, and Xing-Ye Wang, and Yun Hang Gao, and Yan-Xu Chang, and Lu Chen, and Zi-Chang Niu, and Ju-Qing Ai, and Xiu-Mei Gao
March 2020, International journal of molecular medicine,
Hao-Ping Mao, and Xing-Ye Wang, and Yun Hang Gao, and Yan-Xu Chang, and Lu Chen, and Zi-Chang Niu, and Ju-Qing Ai, and Xiu-Mei Gao
January 2021, Frontiers in pharmacology,
Hao-Ping Mao, and Xing-Ye Wang, and Yun Hang Gao, and Yan-Xu Chang, and Lu Chen, and Zi-Chang Niu, and Ju-Qing Ai, and Xiu-Mei Gao
August 2021, Experimental and therapeutic medicine,
Hao-Ping Mao, and Xing-Ye Wang, and Yun Hang Gao, and Yan-Xu Chang, and Lu Chen, and Zi-Chang Niu, and Ju-Qing Ai, and Xiu-Mei Gao
February 2018, Acta pharmacologica Sinica,
Hao-Ping Mao, and Xing-Ye Wang, and Yun Hang Gao, and Yan-Xu Chang, and Lu Chen, and Zi-Chang Niu, and Ju-Qing Ai, and Xiu-Mei Gao
January 2015, PloS one,
Hao-Ping Mao, and Xing-Ye Wang, and Yun Hang Gao, and Yan-Xu Chang, and Lu Chen, and Zi-Chang Niu, and Ju-Qing Ai, and Xiu-Mei Gao
January 2023, Ultrastructural pathology,
Hao-Ping Mao, and Xing-Ye Wang, and Yun Hang Gao, and Yan-Xu Chang, and Lu Chen, and Zi-Chang Niu, and Ju-Qing Ai, and Xiu-Mei Gao
July 2023, Ecotoxicology and environmental safety,
Hao-Ping Mao, and Xing-Ye Wang, and Yun Hang Gao, and Yan-Xu Chang, and Lu Chen, and Zi-Chang Niu, and Ju-Qing Ai, and Xiu-Mei Gao
July 2019, International immunopharmacology,
Hao-Ping Mao, and Xing-Ye Wang, and Yun Hang Gao, and Yan-Xu Chang, and Lu Chen, and Zi-Chang Niu, and Ju-Qing Ai, and Xiu-Mei Gao
January 2024, Ecotoxicology and environmental safety,
Copied contents to your clipboard!